The distribution of parotid gland neoplasms in a veteran population
Autor: | Sonya Malekzadeh, Navin Prasad, Edina Paal, Jessica H. Maxwell, Eshetu Tefera, Adnan S. Hussaini |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
RD1-811 Population Gastroenterology Pleomorphic adenoma 03 medical and health sciences 0302 clinical medicine stomatognathic system Internal medicine Tobacco medicine 030223 otorhinolaryngology education Head and neck cancer Veterans Affairs education.field_of_study medicine.diagnostic_test Veteran business.industry Incidence (epidemiology) Parotid neoplasm Warthin Tumor medicine.disease Parotid gland stomatognathic diseases Fine-needle aspiration medicine.anatomical_structure Otorhinolaryngology RF1-547 030220 oncology & carcinogenesis Warthin tumor Surgery business Research Paper |
Zdroj: | World Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 7, Iss 4, Pp 285-290 (2021) World Journal of Otorhinolaryngology-Head and Neck Surgery |
ISSN: | 2095-8811 |
Popis: | Objective Salivary gland tumors account for 6%–8% of head and neck neoplasms with the parotid gland as the most common primary site. Pleomorphic adenomas (PA) are considered the most common benign parotid gland neoplasms, followed by Warthin tumors (WT). The goal of this study was to investigate the distribution of parotid gland neoplasms among a United States veteran population. Design Retrospective chart review. Setting Washington DC Veterans Affairs Medical Center. Participants Veterans who underwent fine needle aspiration (FNA) for a parotid gland mass from 2000 to 2018 were included. Medical records were reviewed for gender, age, tobacco use, surgery date, and pathology results. Main outcome measures Changes in the distribution of parotid neoplasms and tobacco use over an 18-year period. Results Of 141 patients with parotid gland masses, 86.5% (n = 122) were benign, 9.9% (n = 14) were malignant, and 3.5% (n = 5) were indeterminate. Of benign tumors, WT accounted for the majority at 51.6%, followed by PA at 40.2%. When stratified by decade (2000–2009 and 2010–2018), the proportion of WT compared to all other benign and malignant neoplasms increased from 31.6% to 53.6%, whereas the proportion of PA decreased from 36.8% to 33.3%. The rate of tobacco use was unchanged at approximately 32.0% among our cohort from 2000 to 2018. Conclusion Among our cohort of veteran patients, WT was the most common benign parotid tumor and has increased in incidence over the last two decades despite an unchanged smoking rate. |
Databáze: | OpenAIRE |
Externí odkaz: |